COMMUNIQUÉS West-GlobeNewswire

-
SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%)
15/10/2024 -
Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting
15/10/2024 -
EUROAPI closes the financing of its FOCUS-27 plan
15/10/2024 -
EUROAPI clôt le financement de son plan FOCUS-27
15/10/2024 -
ARC Fertility Selected for BenefitsPRO’s 2024 Luminaries Awards for Humanizing Benefits
15/10/2024 -
Adia Nutrition Inc. Takes Major Steps Forward: Signs LOI for First Clinic and Engages Legal Expertise for Licensing
15/10/2024 -
WellRithms Launches Comp42: Expands Suite of Payment Integrity Services for Workers' Compensation Bill Review, Combats Overpayment and Expedites Dispute Resolution
15/10/2024 -
US Digestive Health Welcomes Seven New Physicians to Its Practice
15/10/2024 -
New AI Tool Helps Americans Get Immediate, Helpful Answers to HSA and Consumer-Directed Benefits Questions
15/10/2024 -
KFNCCC A Regional Leader in Pediatric Cancer Treatment
15/10/2024 -
2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors
15/10/2024 -
RTI International and Codetta Bio™ announce strategic collaboration to accelerate healthcare innovation
15/10/2024 -
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
15/10/2024 -
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder
15/10/2024 -
Elematec Corporation Forms a Business Alliance with and Agrees to Make a Strategic Investment in MEDIROM Healthcare Technologies’ MOTHER Labs Subsidiary
15/10/2024 -
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
15/10/2024 -
Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024
15/10/2024 -
Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery
15/10/2024 -
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
15/10/2024
Pages